Business

January 8, 2014

Boeing, Israel Aerospace Industries’ Arrow 3 Interceptor successfully completes second flight test

The next-generation Arrow 3 interceptor, co-developed by Boeing and Israel Aerospace Industriesí MLM Division, has completed its second successful flight test, further demonstrating its ability to enhance Israelís multi-tier anti-ballistic missile defense strategy.

Arrow 3 is the latest interceptor for the Arrow Weapon System jointly developed by Israel and the United States. It can be launched earlier after threat detection and engage threats at higher altitudes outside the Earthís atmosphere than previous interceptors.

ìThis successful flight test, 10 months after the first, is an important milestone in the decade-long partnership between IAI and Boeing in the Arrow program, and a demonstration of the effective solutions that come from global cooperation in the face of evolving threats,î said Bill Dickerhoff, Arrow program director for Boeing.

The flight was conducted by the Israel Ministry of Defense and the U.S. Missile Defense Agency during a test of Israelís national missile defense system. It began on Jan. 3 at 7:58 a.m. local time when the Arrow 3 interceptor launched from an Israeli test range and flew in accordance with its mission profile before terminating as planned over the Mediterranean Sea.

The Arrow system is the worldís first operational, national missile defense system. Prime contractor IAI-MLM is responsible for interceptor development and production and system integration. Boeing co-develops and co-produces the Arrow 3 interceptor and provides interceptor components for the in-service Arrow 2.




All of this week's top headlines to your email every Friday.


 
 

 

Headlines October 20, 2014

News: Navy grounds ‘Top Guns’ - The F/A-18s needs spare parts and in too many cases they’re being taken from brand new jets. This is a risk to national security and pilots’ lives.   Business: Boeing seeks revised schedule for U.S. aerial tanker - Boeing is revising its master schedule for developing the new U.S. Air Force...
 
 

News Briefs October 20, 2014

New military medical team to help with Ebola in U.S. Defense Secretary Chuck Hagel has ordered the military to prepare and train a 30-member medical support team that could provide short-term help to civilian health professionals if there are more Ebola cases in the United States. His spokesman, Rear Adm. John Kirby, says the team...
 
 

Dragon ‘fires up’ for flight

The Air Force and NATO are undergoing a cooperative development effort to upgrade the avionics and cockpit displays of AWACS aircraft belonging to the 552nd Air Control Wing at Tinker Air Force Base, Okla., and the NATO E-3 Sentrys from Geilenkirchen, Germany. The Diminishing Manufacturing Sources Replacement of Avionics for Global Operations and Navigation, otherwise...
 

 
Boeing photographs

Boeing-built X-37B successfully completes third flight

Unmanned spacecraft concludes record-setting 674-day mission   Boeing photograph A third mission of the Boeing-built X-37B Orbital Test Vehicle was completed on Oct. 17, 2014, when it landed and was recovered at Vandenberg...
 
 

Boeing concludes commercial crew space act agreement for CST-100/Atlas V

Boeing has successfully completed the final milestone of its Commercial Crew Integrated Capability Space Act Agreement with NASA. The work and testing completed under the agreement resulted in significant maturation of Boeing’s crew transportation system, including the CST-100 spacecraft and Atlas V rocket. NASA in July approved the Critical Design Review Board milestone for Boeing’...
 
 

AF to release small business research solicitations

The Air Force Small Business Innovation Research and Small Business Technology Transfer program office is set to release its fiscal year 2015 list of topics Oct. 22, on the SBIR/STTR website.  Small businesses and research institutions with expertise to address the topics’ technology challenges are encouraged to submit proposals. During 2014, the Defense Department SBIR...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>